1. Effects of pirmenol HCI on electrophysiologic properties of cardiac Purkinje fibers;Reder, R.F.; Danilo, P.; Rosen, M.R.;Eur J Pharmacol,1980
2. Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics;Hammill, S.G.; Shand, D.G.; Routledge, P.A.; Hindman, M.C.; Baker, J.T.; Pritchett, E.L.C.;Circulation,1982
3. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study;Anderson, J.L.; Lutz, JR, Nappi; J.M.;Am J Cardiol,1984
4. Pirmenol in termination of paroxysmal supraventicular tachycardia;Toivonen, L.K.; Nieminen, M.S.; Manninen, V.; Frick, M.N.;Ann Clin Res,1985
5. Electrophysiological and cardiovascular effects of pirmenol, a new class 1 antiarrhythmic drug;Dukes, I.D.; Vaughan Williams, E.M.; Dennis, P.D.;J Cardiovasc Pharmacol